HomeEisai, Biogen’s Alzheimer’s drug price should not dent demand – analystsFILE PHOTO: A sign marks a Biogen facility in Massachusetts

FILE PHOTO: A sign marks a Biogen facility in Massachusetts

FILE PHOTO: A sign marks a Biogen facility in Cambridge, Massachusetts, U.S. January 26, 2017. REUTERS/Brian Snyder

Most Read

How Trump’s Pentagon pick Hegseth fell out of love with the U.S. military

November 15, 2024

Palantir shares rally to fresh record on plans for move to Nasdaq

November 15, 2024

EV companies, battery makers urge Trump not to kill vehicle tax credits

November 15, 2024

Musk expands lawsuit against OpenAI, adding Microsoft and antitrust claims

November 15, 2024